Matrix metalloproteinase-19 (MMP-19), unlike other members of the MMP family, is expressed in basal keratinocytes of intact epidermis whereas keratinocytes in suprabasal and higher epidermal layers express this enzyme only during cutaneous disorders. As the activity of MMP-19 effects proliferation, migration, and adhesion of keratinocytes we examined whether transcription factors involved in keratinocyte differentiation repress the expression of MMP-19. Using luciferase reporter assays, POU transcription factors Tst-1 (Oct-6) and Skn-1a (Oct-11) markedly downregulated the activity of MMP-19 promoter in COS-7 cells and HaCaT keratinocytes. Tst-1 alone was able to inhibit 85% of the promoter activity. Skn-1a exhibited a weak inhibitory effect although it synergistically increased effects of Tst-1. HaCaT cells stably transfected with Tst-1 showed a strong decrease of activity of MMP-19 promoter that correlated with suppression of MMP-19, cytokeratin 14 and 5, decreased cell proliferation, and altered expression of involucrin and loricrin. The expression of MMP-9 was also significantly reduced in Tst-1 expressing keratinocytes. MMP-2 was substantially affected during its activation whereas the expression of MMP-28 was unchanged. Our results suggest that Tst-1 and Skn-1a regulate expression of MMPs in keratinocytes and effect both the expression and activation of these proteolytic enzymes.
INTRODUCTION
The mammalian epidermis is a stratified and renewable protective barrier characterized by keratinocyte differentiation. Keratinocytes adjacent to the basement membrane represent cells with high proliferative potential that undergo differentiation as they enter the suprabasal compartment. These keratinocytes characterized by expression of cytokeratin 5 and 14 (K5 and K14) assemble in a single-cell layer called stratum germinativum (Fuchs and Green, 1980; Fuchs, 1995) . During epidermal differentiation in the stratum spinosum, K5 and K14 are replaced by K1 and K10 (Zhu et al., 1999) . In upper layers, keratinocytes express proteins typical for the differentiation state such as small prolin-rich protein-2a, loricrin, involucrin, and profilaggrin (Gibbs et al., 1990; Mehrel et al., 1990; Hohl et al., 1993; Fischer et al., 1996; Jang et al., 1996; Eckert et al., 2004) . In addition to characteristic changes in the expression of structural proteins, various regulatory proteins, adhesion molecules, and proteases undergo tight regulation in order to maintain functions of the epidermal barrier (Turksen, 2004) . This regulation is controlled by ubiquitous and specific factors. Among the ubiquitous transcription factors, AP1, AP2, and Sp1 were reported to be involved in gene regulation during differentiation of keratinocytes (Fuchs, 1995; Eckert et al., 1997a, b) . In addition, transcription factors expressed predominantly in the epidermis include Tst-1 (Testes-1, Oct-6) and Skn-1a (Skin1a/Epoc-1/Oct-11) that belong to the POU family of transcription factors. Skn-1a is able to enhance epidermal stratification and transactivate promoters for K10 and small prolin-rich protein-2a (Andersen et al., 1993; Fischer et al., 1996; Hildesheim et al., 1999 Hildesheim et al., , 2001 ). Both Skn-1a and Tst-1 repress K14 that is downregulated upon commitment to terminal differentiation (Faus et al., 1994; Sugihara et al., 2001 ).
Matrix metalloproteinases (MMPs) that are responsible for the degradation of various components of the extracellular matrix are upregulated in the skin under pathologic conditions such as cutaneous tumors, infections, or chronic wounds. MMPs that are indispensable for the completion of the wound healing process (Madlener et al., 1998; Pilcher et al., 1998; Pilcher et al., 1999) are generally downregulated in the intact epidermis. In contrast, MMP-19 shows a different expression pattern in the epidermis. It is typically expressed in the basal layer of healthy interfollicular epidermis but upregulated in suprabasal and spinous layers in psoriasis, eczema, and tinea (Sadowski et al., 2003b; Suomela et al., 2003) . MMP-19 is also dysregulated in chronic wounds and cutaneous tumors (Impola et al., , 2005 Sadowski et al., 2005) . The proteolytic activity of MMP-19 is responsible for increased proliferation of keratinocytes by activating the IGF/ IGF-1R signaling pathway and for promoting the migratory behavior (Sadowski et al., 2003a) . Further promigratory stimuli originate from processing of extracellular matrix proteins such as laminin 5 g2, type IV collagen, and fibrin (Sadowski et al., 2003a (Sadowski et al., , 2005 .
Although we reported that increased calcium concentrations and E-cadherin mediate repression of MMP-19 in keratinocytes (Sadowski et al., 2003a) , its regulation in the epidermis remains largely unknown. Uncovering the mechanism leading to accurate repression of MMP-19 could help to define its pathophysiologic role in the epidermis, especially its contribution to keratinocyte proliferation and migration.
In this study we report on the regulation of MMP-19 and other epidermally expressed MMPs by transcription factors Tst-1 and Skn-1a that are involved in keratinocyte differentiation. We have shown that Tst-1 and Skn-1a downregulate the activity of MMP-19 promoter and thus suppress the expression of this MMP. The expression of MMP-28 remained unchanged in keratinocytes expressing Tst-1 whereas that of MMP-9 was markedly reduced. MMP-2 showed slightly reduced expression whereby its activation was decreased substantially. Thus, the POU family members Tst-1 and Skn1a are transcription factors that exert differential regulation of MMPs in keratinocytes.
RESULTS
Transcription factors Tst-1 and Skn-1a downregulate Our previous studies showed that MMP-19 is constitutively expressed in the stratum basale of interfollicular epidermis and that this expression pattern correlates with that of K14 (Sadowski et al., 2003a, b) . Because of the unique expression pattern of MMP-19 and the proteolytic activity, which effects migration and adhesion of keratinocytes and promotes cell proliferation, we asked which factors regulate the expression of MMP-19 in the epidermis. As K14 is downregulated by transcription factors Tst-1 (Oct-6) and Skn-1a (Oct-11) we studied their impact on the expression of MMP-19. Tst-1 and Skn-1a are specifically involved in the regulation of keratinocyte differentiation (Faus et al., 1994; Andersen et al., 1997; Hildesheim et al., 1999; Sugihara et al., 2001) . COS-7 cells were transiently transfected with expression vectors containing either Tst-1 or Skn-1a. Regulatory effects were measured using the dual-luciferase assay and a vector construct containing the 1898-bp stretch of the 5 0 -flanking promoter region of mmp-19 gene (Mueller et al., 2000) .
Although both Tst-1 and Skn-1a exhibited the same tendency to inhibit the activity of MMP-19 promoter only Tst-1 showed significant inhibition. The Tst-1-dependent inhibition of the promoter activity reached 90% (Figure 1a) . No clear relationship between gene dosage and the promoter activity could be observed ( Figure 1a ). As Tst-1 and Skn-1a are expressed in the suprabasal layers alongside, we investigated their concurrent influence on the MMP-19 promoter. As shown in Figure 1a these two factors may exhibit a synergistic inhibitory effect on the MMP-19 promoter at low concentrations. The simultaneous transfection of 0.005 mg of each expression vector bearing Tst-1 or Skn-1a (i.e., 5% of transfected plasmid DNA) reached 65% inhibition of the promoter activity ( Figure 1a) . When transfected alone, Skn-1a did not show significant inhibition in COS-7 cells and Tst-1 reached a comparable inhibitory effect at concentrations that are five to 10 times higher ( Figure  1a) .
In order to prove that Tst-1 and Skn-1a affect the promoter activity of MMP-19 in keratinocytes we transiently transfected HaCaT cells with the transcription factors (Figure 1b) . Similarly to the effects observed in COS-7 cells, Tst-1 showed higher inhibition (90%) in comparison to Skn-1a (60%) and no dose-dependent inhibition was observed. Thus, both POU factors are able to inhibit the promoter activity of MMP-19 in keratinocytes whereby Tst-1 appears to have higher inhibitory capacity.
Because of the profound effects of Skn-1a and Tst-1 on the activity of MMP-19 promoter, we examined whether the 1,932 bp long 5 0 -flanking region of mmp-19 gene possesses binding sites for these transcription factors (Mueller et al., 2000) . Although we could not find a consensus sequence for Skn-1a, the promoter analysis revealed a possible binding site for Tst-1 starting at position À278 (Figure 1c ). This may lead to the presumption that Tst-1 can theoretically use both the direct and indirect way of promoter regulation whereas Skn1a regulates the promoter activity of MMP-19 indirectly via protein-protein interaction. Skn-1a represses K14 promoter via interaction with cAMP response element binding protein (CREB)-binding protein (Sugihara et al., 2001 ) and the analysis of the MMP-19 promoter also disclosed consensus binding sequences for CREB and CREB protein binding protein at positions À1917, À1898, and À1398 ( Figure 1c ).
Inhibition of MMP-19 expression correlates with decreased proliferation in keratinocytes overexpressing Tst-1
To gather further information on processes that are parallel to the inhibition of MMP-19 we generated stably transfected HaCaT cells expressing Tst-1, especially as the promoter of MMP-19 contains a consensus binding site for this factor and Tst-1 exhibited more pronounced effects than Skn-1a. Two clones Tst-1/12 and Tst-1/14 that showed different expression levels of Tst-1 were selected for further analysis (Figure 2a ). Both clones exhibited tendency to reduce the activity of MMP-19 promoter, however, only clone Tst-1/14 that showed strong overexpression of Tst-1 could markedly and significantly inhibit the promoter activity ( Figure 2b ). In addition, both clones expressing Tst-1 showed decreased cell proliferation ( Figure 2c ). The reduced promoter activity and cell proliferation interrelated with other known effects of Tst-1. Both clones exhibited increased expression of loricrin ( Figure 2f ) whereas involucrin was downregulated (Figure 2d and e). The downregulation of involucrin is in respect of epidermal differentiation rather unforeseen as involucrin is accepted as a marker of keratinocyte differentiation. However, investigations by Eckert and his co-workers (Welter et al., 1996; Eckert et al., 2004) showed that the activity of involucrin promoter in vitro is suppressed by POU factors such as Tst-1 (SCIP) and Skn-1a. Moreover, both Tst-1-expressing clones downregulated the expression of K14 (Figure 2g ). The expression of K5 was also reduced although Tst-1/12 showed higher impact on K5 production ( Figure 2h ). Thus, cells that ectopically express Tst-1 suppressed MMP-19 promoter and behaved as keratinocytes undergoing epidermal differentiation.
Impact of Tst-1 on MMP expression in keratinocytes
As the ectopic expression of Tst-1 in HaCaT keratinocytes inhibited the promoter activity of MMP-19, we asked if this transcription factor affects also the protein amount of MMP-19 and other MMPs expressed by keratinocytes, especially gelatinase A and B, and MMP-28 (Lohi et al., 2001) . MMP-19 could not be detected by immunoblotting of cell lysates prepared from stably transfected Tst-1 clones (Figure 3 ), thus, the protein level correlated with the decreased promoter activity (Figure 2b) . However, the inhibited expression and reduced promoter activity did not correlate with messenger RNA levels of MMP-19 that showed tendency to decrease but no significance at Po0.05 (Figure 3b) . Expression of MMP-28 in the Tst-1 clones, analyzed by immunoblotting, did not differ from untransfected HaCaT cells (Figure 3c ). The expression of MMP-9 was substantially reduced (60%) as could be seen in gelatin zymography carried out with conditioned media of cells cultured with fetal calf serum (FCS) (Figure 3d and e) . Although the expression level of MMP-2 decreased only about 20% as elucidated from densitometric analysis of pro-MMP-2, the activation of MMP-2 was changed considerably. The Tst-1 clones showed 50% reduction of the gelatinolytic activity of the 62-kD form of MMP-2 (Figure 3d and e). Similar inhibitory effects were found in cells cultured without FCS (not shown). As the activation of pro-MMP-2 was more affected than its expression it is possible that other proteases or inhibitors participating in the activation of MMP-2 are affected by Tst-1 as well. www.jidonline.org 1109
DISCUSSION
In this study, we have found that transcription factors of the POU family Tst-1 and Skn-1a involved in the epidermal differentiation process control expression of MMP-19 and that Tst-1 influences also MMP-9 and MMP-2, but not MMP-28. Although several other MMPs could be potentially produced by basal keratinocytes their expression is generally upregulated after epidermal injury. Thus, MMP-1 and MMP-3 are expressed by migrating keratinocytes in the leading epidermal edge during wound closure (Pilcher et al., 1998 (Pilcher et al., , 1999 . Although MMPs are essential for efficient wound healing and play important role during development of cutaneous tumors, it seems that they do not exert important physiological function in healthy epidermis. At the moment, we do not know why MMP-19 is expressed by basal keratinocytes and which functions it exerts but as it activates the IGF/IGF-1R pathway it may contribute to proliferation of basal keratinocytes and, thus, to inhibition of keratinocyte differentiation (Sadowski et al., 2003a) . Indeed, IGF-1 is considered to possess important regulatory functions in the epidermis as calcium-induced differentiation of keratinocytes is inhibited in the presence of IGF-1 (Wertheimer et al., 2000) . The downregulation of MMP-19 in suprabasal layers might be then needed for the onset of the epidermal differentiation program. This is supported by the expression pattern of MMP-19 in cutaneous diseases such as psoriasis, tinea, or eczema, all of which exhibit proliferative disturbance (Sadowski et al., 2003b) . MMP-19 may also be involved in keratinocyte movement or release from the basement membrane as it possesses capacity to process basement membrane proteins such as type IV collagen, nidogen-1, tenascin C, and laminin 5 g2 (Stracke et al., 2000; Titz et al., 2004; Sadowski et al., 2005) . The MMP-19-dependent processing of laminin 5 g2 chain leads to an integrin switch favoring signaling via a3b1 integrin, which promotes keratinocyte migration (Sadowski et al., 2005) . As the expression pattern of MMP-19 in the epidermis follows that of K14 in the intact epidermis as well as in epidermal diseases such as psoriasis, eczema, and tinea (Sadowski et al., 2003b) we assumed that MMP-19 might be regulated in keratinocytes in a similar manner as K5 and K14 (Fuchs and Green, 1980; Faus et al., 1994; Fuchs, 1995; Zhu et al., 1999; Sugihara et al., 2001) . As Skn-1a and Tst-1 inhibit the expression of K5 and K14 and are expressed primarily in differentiating keratinocytes (Goldsborough et al., 1993; Faus et al., 1994; Sugihara et al., 2001) we studied if these transcription factors also influence the expression of MMP-19. Transient transfection of either COS-7 or HaCaT cells with expression vectors harboring Tst-1 led to a dramatic decrease of MMP-19 promoter activity. In contrast, Skn-1a was less effective in HaCaT cells and showed no significant effect in COS-7 cells. The concurrent expression of these transcription factors augmented their inhibitory effect on the MMP-19 promoter. Based on this effect it could be assumed that Skn-1a and Tst-1 exhibit a synergistic inhibitory effect on MMP-19 in suprabasal layers. Similar synergy was observed in mice harboring deletion of both Tst-1 and Skn-1a/i (Andersen et al., 1997) . Although the epidermis of mice with the deletion of Tst-1 develops without obvious changes, the epidermis of mice deleted for both Skn-1a/i and Tst-1 is hyperplastic and fails to suppress expression of K14.
To confirm that the suppression of MMP-19 promoter parallels other processes known for the activity of Tst-1, for instance keratinocyte differentiation, stably transfected HaCaT cells were generated. As expected, ectopic expression of Tst-1 upregulated the late differentiation marker loricrin, www.jidonline.org 1111 downregulated K5 and K14, and reduced the proliferation, which reflects a shift towards keratinocyte differentiation (Faus et al., 1994; Welter et al., 1996; Andersen et al., 1997; Jang et al., 2000) . In addition to the suppressed activity of MMP-19 promoter, Tst-1 overexpression reduced MMP-19 at the protein level. However, the decrease at messenger RNA level was not significant pointing to an additional posttranscriptional regulatory mechanism.
The analysis of the 5 0 -flanking region of mmp-19 gene revealed one consensus binding motif for Tst-1 but none for Skn-1a. Thus, Tst-1 might act on the MMP-19 promoter directly via the possible binding site as well as indirectly whereas Skn-1a seems to regulate MMP-19 indirectly. Nevertheless, we cannot exclude the possibility that cisacting elements for Skn-1a lay outside the region studied. Such indirect regulations seem to be common among POU factors. It has been shown that promoters of acetylcholine receptor a3 and myeline P o gene are regulated by Tst-1 indirectly via protein-protein interaction instead of binding to a DNA motif (Monuki et al., 1993; Jang et al., 2000) . Tst-1 can also interact with high-mobility group protein HMG-I/Y and thus increase its affinity to AT-rich elements (Leger et al., 1995) . With regard to indirect effects of Skn-1a, it has been shown that this transcription factor modulates promoter activity via binding to CREB and CREB binding protein/ p300. In this way, Skn-1a represses the promoter of K14 (Sugihara et al., 2001) .
Although numerous publications document the expression of MMPs during wound healing and in various pathologic processes in the skin (Madlener et al., 1998; Pilcher et al., 1999; Fisher et al., 2001; Inomata et al., 2003) , factors regulating their expression are mostly unknown (Parks and Mecham, 1998 ). Here we show that MMP-19 typically expressed in basal keratinocytes is downregulated by transcription factors Skn-1a and Tst-1a that are involved in epidermal differentiation. However, MMP-28, phylogenetically the nearest MMP, was not affected by Tst-1. In contrast, MMP-9 that colocalizes with involucrin, (Kobayashi et al., 2001) , was also substantially inhibited at the expression level. Analogous to MMP-19, the inhibition of MMP-9 might be also affected by Tst-1 because of its consensus binding motif positioned similarly as in the promoter of MMP-19. The expression of MMP-2 in HaCaT clones overexpressing Tst-1 was slightly reduced but its conversion to the active form was reduced considerably. This might imply that another protease involved in the activation of MMP-2, for instance MT1-MMP, or an MMP-2 inhibitor is also affected by Tst-1 (Hernandez- Barrantes et al., 2000; Overall et al., 2000) .
Taken together, transcription factors Tst-1 and Skn-1a that are expressed in suprabasal layers suppress the activity of MMP-19 promoter, which in turn lead to downregulation of MMP-19 expression. Tst-1 and Skn-1a affect also expression and activation of MMP-9 and MMP-2, respectively, but not MMP-28. Thus, Tst-1 and Skn-1a may be new important tissue-specific regulators of matrix metalloproteinases. With respect to differentiating events of the epidermis we propose that the downregulation of MMP-19, analogous to the repression of K5 and K14, marks one of the earliest steps in keratinocyte differentiation.
MATERIALS AND METHODS

Cell culture and transfection
The HaCaT cell line was generously provided by N. Fusenig (DKFZ, Heidelberg, Germany). HaCaT and COS-7 cells were maintained at 371C in a humidified atmosphere of 5% CO 2 in DMEM (PAA, Linz, Austria) supplemented with 10% FCS and 50 U/ml penicillin and 50 mg/ml streptomycin. The full-length cDNA of human Tst-1 and Skn-1a, kindly provided by B. Andersen (University of California, Irvine, CA), were subcloned into pcDNA3.1 (Invitrogen, Carlsbad, CA). These vectors were transfected into HaCaT and COS-7 cells using FuGENE 6 according to the manufacturer's instructions (Roche, Mannheim, Germany) . Using this agent, we have routinely reached 70-80% transfection in COS-7 cells and 20-25% transfection in HaCaT cells. For generation of stably transfected clones, HaCaT cells were selected in 0.6 mg/ml G418 (PAA, Linz, Austria).
All experiments of this study were performed according to institutional approvals of the Institute of Biochemistry, University of Kiel.
Promoter activity
The promoter activity of MMP-19 was analyzed with the dual luciferase assay (Promega, Madison, WI) using a firefly luciferase vector containing a 1898-bp stretch of the 5 0 -flanking region (-1898/ LUC) of the mmp-19 gene (Mueller et al., 2000) . For transient transfection, HaCaT and COS-7 cells at 5 Â 10 4 cells/well were transfected with a total amount of 0.1 mg DNA using FuGENE 6 (Roche) in serum-free DMEM containing 0.03 mM CaCl 2 . For each transfection 0.06 mg of À1898/LUC vector and 0.02 mg pRL-TK renilla luciferase vector as an internal control were co-transfected with 0.005, 0.01, or 0.02 mg (5, 10, or 20% of plasmid DNA used for transfection) of either Tst-1 or Skn-1a vector. To aim equal amounts of DNA empty pcDNA3.1 vector was added to 0.1 mg (100% of transfected plasmid DNA). As control 0.02 mg of empty pcDNA3.1 vector was used. To analyze the synergistic effect of Tst-1 and Skn-1a co-transfection with 5% (0.005 mg) and 10% (0.01 mg) of both vectors was carried out in COS-7 cells. Transfected cells were lysed after 48 hours cultivation. Luminescence was measured using a singlesample luminometer (TD/20, Turner Design, CA) according to the manufacturer's manual (Promega). In order to measure MMP-19 promoter activity in HaCaT cells ectopically expressing Tst-1, cells were transfected with 0.07 mg -1898/LUC and 0.03 mg pRL-TK renilla luciferase.
All assays were performed in quadruplicate in three separate experiments. The average of these quadruplicate was taken to obtain the relative luciferase activity, which is expressed in relative light units as defined by the ratio of firefly to renilla luciferase activity multiplied by the factor 10 4 . Data are presented as average7SD and
show the percentage of relative light units change against the control. Results were analyzed using student's two-tailed paired t-test.
Immunoblotting and gelatin zymography
Cells were lysed for 45 minutes on ice in 10 mM Tris-HCl buffer (pH 7.5) containing 1 mM EDTA, 150 mM NaCl, 1% Triton X-100, and Complete TM proteinase inhibitor (Roche, Germany). Protein content was determined using the bicinchoninic acid protein assay (Pierce, Rockford, IL). Equal amounts of proteins were separated by SDS-PAGE, followed by electrophoretic transfer onto a PVDF membrane (Macherey-Nagel, Dü ren, Germany). Membranes were blocked with 3% non-fat milk in TNT buffer containing 20 mM Tris-HCl, 500 mM NaCl, and 0.05% Tween-20, pH 7.5. For detection, polyclonal rabbit anti-MMP-19 (Chemicon, Temecula, CA), rabbit anti-loricrin, rabbit anti-keratin 5, rabbit anti-keratin 14 (all Covance, Berkeley, CA), and monoclonal mouse anti-involucrin antibodies (Sigma, St Louis, MO) were used. For immunoblotting, the purchased anti-MMP-19 antibodies (Chemicon) were preferred as they better reflected the quantitative differences than the monoclonal antipropeptide domain antibodies CK 8/4. MMP-28 expression was detected using polyclonal rabbit anti-MMP-28 antibodies, kindly provided by S. Illman (University Helsinki, Finland). Bound antibodies were detected using peroxidase-conjugated goat antirabbit antibodies (Pierce, Rockford, IL) and the enhanced chemiluminescence plus Western Blotting Detection System (Amersham Biosciences, UK). Signals were recorded with a Luminescent Image Analyzer (FujiFilm, Tokyo, Japan). For zymography, conditioned media supplemented with FCS or without FCS standardized for cell numbers were mixed with a nonreducing SDS sample buffer and loaded onto 10% polyacrylamide gels containing 1 mg/ml gelatin (Sigma-Aldrich, Steinheim, Germany). After electrophoresis, the gels were soaked in 2.5% Triton X-100 to remove SDS. Gelatinolytic activities were developed in 50 mM Tris-HCl buffer containing 5 mM CaCl 2 , and 0.05% Triton X-100, pH 7.5 at 371C for 24 hours. Lytic bands were visualized by staining the gels with Coomassie blue R-250. Densitometric analysis of lytic bands was carried out using the 2D AIDA image analyzer software (RayTest, Straubenhardt, Germany). Values are given in percent inhibition to untransfected HaCaT cells.
RNA isolation and RT-PCR
Total RNA from HaCaT cells was isolated using Trizol s according to the manufacturer's instructions (Invitrogen, Carlsbad, CA) . For the generation of cDNA, 1 mg RNA was incubated with 100 pmol oligo dT primer and 20 U of Enhanced Avian HS reverse transcriptase (Sigma, Germany) for 60 minutes at 421C. Glyceraldehyde-3-phosphate dehydrogenase and Tst-1 were amplified in 22 and 30 cycles, respectively. Each cycle consisted of denaturation at 951C for 45 seconds, annealing for 30 seconds at 581C (Tst-1) or 501C (glyceraldehyde-3-phosphate dehydrogenase), extension at 721C for 60 seconds. The reaction was thereby kept in the exponential range of amplification to obtain semiquantitative results. Oligonucleotide primers were as follows: Tst-1, 5 0 -GCACCTAGAACACGG CAAG-3 0 and 5 0 -CTTGAACTGCTTGGCGAACT-3 0 (product length, 526 bp); glyceraldehyde-3-phosphate dehydrogenase, 5 0 -GAGAT GATGACCCTTTTGG-3 0 and 5 0 -GTGAAGGTCGGAGTCAACG-3 0 (product length, 386 bp). cDNA synthesis, quantitative real-time PCR, and calculation of C T values for MMP-19 and involucrin were carried out as described (Held-Feindt et al., 2006) . PCR was performed using the ABI 7700 Prism Sequence Detection System and TaqMan primer probes (Applied Biosystems, Foster City, CA). Each sample was run in three replicates. C T values were analyzed using student's two-tailed paired t-test; significances are indicated by asterisks (*Po0.05 and **Po0.01).
